Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 9—September 2025

Research Letter

Human Babesiosis Caused by Babesia venatorum, Russia, 2024

Author affiliation: First Moscow State Medical University (Sechenov University), Moscow, Russia (O.P. Zelya, I.V. Kukina, V.V. Garin); Research Center of Neurology, Moscow (L.S. Karan); Centre for Strategic Planning of the Federal Medical and Biological Agency, Moscow (L.S. Karan); Sayanogorsk Interdistrict Hospital, Sayanogorsk, Russia (E.A. Krasilovskaya)

Suggested citation for this article

Abstract

We report a case of acute babesiosis in a splenectomized 63-year-old man in Siberia, Russia. We confirmed the causative agent, Babesia venatorum, by PCR. Our study demonstrated a change in the structure of the parasite population, from single parasite invasion of erythrocytes to multioccupancy, without an increase in parasitemia level.

Babesiosis is an emerging tickborne infection caused by intraerythrocytic protozoa. To date, researchers have described more than 50 cases of babesiosis in humans in Europe, almost always fulminant in splenectomized patients and typically attributed to Babesia divergens. Some recent reports also describe several cases of human infection with B. venatorum, associated with milder infections than those caused by B. divergens (1). Researchers have also described sporadic cases of babesiosis caused by infection with Babesia microti and B. divergens in Asia-Pacific regions (2,3), but the practically asymptomatic course of the human infection with B. venatorum is more common (4). Although reports have noted detection of Babesia spp. DNA in Ixodes persulcatus ticks in Siberia (5), cases of human infections have yet to be reported in that region of Russia.

We report the case of a 63-year-old man who resided in a forested, mountainous area of Khakassia, East Siberia, Russia, and had undergone splenectomy. On September 30, 2024, the man sought treatment for an influenza-like syndrome with signs and symptoms that included a fever of 38°C, severe general weakness, darkening of urine, a decrease in diuresis, jaundice, dyspnea, and stomachache. Attending physicians admitted the patient to the hospital on October 2, 2024 (Table). The patient reported no awareness of a tick bite and had received no blood products in the previous 3 months.

Blood smears obtained on hospital admission tested positive for Plasmodium spp. However, because the patient reported no recent travel to malaria-endemic areas, we sent the blood samples for retesting at Sechenov University (Moscow, Russia), where results confirmed babesiosis. We then examined the blood smears after Romanovsky-Giemsa staining, noting the paired forms diverging at a wide angle (≤180°), which is characteristic of both B. divergens and B. venatorum (Appendix Figure 1).

We screened DNA samples extracted from the blood smears for B. divergens, B. microti, and B. venatorum by PCR, using methods described previously (6). We partially sequenced the 18S rRNA gene (1,112 bp; GenBank accession no. PV086113) (5). We aligned, compared, and analyzed the resulting nucleotide sequences and reference sequences downloaded from GenBank by using MEGAX (7). We also reconstructed a phylogenetic tree (Appendix Figure 2). Using forward and reverse primers form 18S RNA of Babesia spp. from Europe, we were able to detect only B. venatorum DNA.

Figure

Dynamics of the parasite population in erythrocytes in case-patient in study of human babesiosis caused by Babesia venatorum, Russia, 2024. As the infection progressed with constant parasitemia (<3%), 4 main populations of infected red blood cells were seen: 1 parasite, 2 parasites, 4 parasites, and >4 multioccupancy (>4 parasites).

Figure. Dynamics of the parasite population in erythrocytes in case-patient in study of human babesiosis caused by Babesia venatorum, Russia, 2024. As the infection progressed with constant parasitemia (<3%),...

We started etiotropic treatment for the patient 3 days from the time we initially detected intraerythrocytic parasites and identified the causative agent as Babesia spp. The patient responded to therapy (clindamycin and quinine sulfate), and by day 9 of treatment, parasites were no longer detectable with microscopy (Table). We noted that the ratio of erythrocytes invaded by >1 trophozoite changed as the infection progressed. Four days after symptom onset, single trophozoites and pairs (figure 8 pattern) predominated. On the 8th day of infection, with the same level of parasitemia, almost half of the infected erythrocytes contained ≥4 trophozoites (Figure). Parasites continued to divide intensively but did not leave the host cell. Prior research has noted multiple parasites present in individual erythrocytes during fulminant infections in humans (8) and in heavily infected in vitro cultures (9). Results of such studies suggests that multioccupancy of trophozoites in the erythrocyte prevents a sharp increase in parasitemia and helps to preserve the parasite population in the host (9). However, the phenomenon we observed occurred at both high (>23%) and low (<3%) parasitemia.

Our study of this unique case of human babesiosis in Siberia, Russia, provides molecular evidence that the etiologic agent was B. venatorum. Prior research noted the Asia variant of B. venatorum in asymptomatic persons from China (4). B. divergens infection in splenectomized humans could lead to death, even with timely treatment (1). However, the similar course and positive outcome of babesiosis in our patient resembled those in cases previously reported in Europe (1), suggesting that the causative agent of the disease was B. venatorum, which we confirmed by PCR.

Our patient resided in a village located in a forested area, which is a natural habitat for ticks. The man’s work involved staying in the forest, again increasing his risk for tick bites. The fact that the patient did not notice a tick bite is not unusual. Only 50% to 70% of patients with tickborne diseases recall being bitten by a tick (2). Considering the ability of B. venatorum to be transmitted transovarially and transstadially within I. persulcatus ticks, it is possible for a person to become infected through the bite of a tick nymph, which is smaller and less noticeable than the adult (10).

In conclusion, our case study revealed the potential risk of B. venatorum infection for persons living in Siberia, Russia. Clinicians should be aware that infection can occur as an influenza-like illness and may go unnoticed in immunocompetent persons.

Dr. Zelya is a parasitologist working as an assistant professor at Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Moscow, Russia. Her primary research interests are centered on laboratory diagnostics and epidemiology of parasitic diseases.

Top

Acknowledgment

We are deeply grateful to Svetlana L. Lukovenko for her collaboration in preparing and sending us blood products (thick and thin blood films) with intraerythrocytic protozoa.

Top

References

  1. Hildebrandt  A, Zintl  A, Montero  E, Hunfeld  K-P, Gray  J. Human babesiosis in Europe. Pathogens. 2021;10:1165. DOIPubMedGoogle Scholar
  2. Zhou  X, Xia  S, Huang  JL, Tambo  E, Zhuge  HX, Zhou  XN. Human babesiosis, an emerging tick-borne disease in the People’s Republic of China. Parasit Vectors. 2014;7:509. DOIPubMedGoogle Scholar
  3. Kumar  A, O’Bryan  J, Krause  PJ. The global emergence of human babesiosis. Pathogens. 2021;10:1447. DOIPubMedGoogle Scholar
  4. Jiang  JF, Zheng  YC, Jiang  RR, Li  H, Huo  QB, Jiang  BG, et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of “Babesia venatorum” infection in China: a descriptive study. Lancet Infect Dis. 2015;15:196203. DOIPubMedGoogle Scholar
  5. Rar  VA, Epikhina  TI, Livanova  NN, Panov  VV. Genetic diversity of Babesia in Ixodes persulcatus and small mammals from North Ural and West Siberia, Russia. Parasitology. 2011;138:17582. DOIPubMedGoogle Scholar
  6. Michelet  L, Delannoy  S, Devillers  E, Umhang  G, Aspan  A, Juremalm  M, et al. High-throughput screening of tick-borne pathogens in Europe. Front Cell Infect Microbiol. 2014;4:103. DOIPubMedGoogle Scholar
  7. Kumar  S, Stecher  G, Li  M, Knyaz  C, Tamura  K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35:15479. DOIPubMedGoogle Scholar
  8. Kukina  IV, Zelya  OP. Extraordinary high level of propagation of Babesia divergens in severe human babesiosis. Parasitology. 2022;149:11603. DOIPubMedGoogle Scholar
  9. Lobo  CA, Cursino-Santos  JR, Singh  M, Rodriguez  M. Babesia divergens: a drive to survive. Pathogens. 2019;8:95. DOIPubMedGoogle Scholar
  10. Bonnet  S, Brisseau  N, Hermouet  A, Jouglin  M, Chauvin  A. Experimental in vitro transmission of Babesia sp. (EU1) by Ixodes ricinus. Vet Res. 2009;40:21. DOIPubMedGoogle Scholar

Top

Figures
Table

Top

Suggested citation for this article: Zelya OP, Kukina IV, Karan LS, Krasilovskaya EA, Garin VV. Human babesiosis caused by Babesia venatorum, Russia, 2024. Emerg Infect Dis. 2025 Sep [date cited]. https://doi.org/10.3201/eid3109.250319

DOI: 10.3201/eid3109.250319

Original Publication Date: August 19, 2025

Table of Contents – Volume 31, Number 9—September 2025

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Olga P. Zelya, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Malaya Pirogovskaya st., 20-1, Moscow 119435, Russia

Send To

10000 character(s) remaining.

Top

Page created: August 05, 2025
Page updated: August 19, 2025
Page reviewed: August 19, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external